Merrimack Pharmaceuticals' Series C Round

Merrimack Pharmaceuticals raised a round of funding on May 14, 2004.

Merrimack Pharmaceuticals (NASDAQ: MACK) is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the treatment of serious diseases, …

Articles about Merrimack Pharmaceuticals' Series C Round: